Bio-Rad Laboratories Narrows FY2025 Sales Guidance from $2.541B-$2.606B to $2.567B-$2.593B vs $2.520B Est
Benzinga Newsdesk 1 year ago
NewsGuidance
Bio-Rad Laboratories (NYSE:BIO) narrows FY2025 sales outlook from $2.541 billion-$2.606 billion to $2.567 billion-$2.593 billion vs $2.520 billion estimate.
Bio-Rad Laboratories (NYSE:BIO) narrows FY2025 sales outlook from $2.541 billion-$2.606 billion to $2.567 billion-$2.593 billion vs $2.520 billion estimate.